Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 83

Similar articles for PubMed (Select 8896514)

1.

The effect of a monoclonal antibody to tumor necrosis factor on survival from childhood cerebral malaria.

van Hensbroek MB, Palmer A, Onyiorah E, Schneider G, Jaffar S, Dolan G, Memming H, Frenkel J, Enwere G, Bennett S, Kwiatkowski D, Greenwood B.

J Infect Dis. 1996 Nov;174(5):1091-7.

2.

Anti-TNF therapy inhibits fever in cerebral malaria.

Kwiatkowski D, Molyneux ME, Stephens S, Curtis N, Klein N, Pointaire P, Smit M, Allan R, Brewster DR, Grau GE, et al.

Q J Med. 1993 Feb;86(2):91-8.

PMID:
8329024
3.

Effect of iron chelation therapy on mortality in Zambian children with cerebral malaria.

Thuma PE, Mabeza GF, Biemba G, Bhat GJ, McLaren CE, Moyo VM, Zulu S, Khumalo H, Mabeza P, M'Hango A, Parry D, Poltera AA, Brittenham GM, Gordeuk VR.

Trans R Soc Trop Med Hyg. 1998 Mar-Apr;92(2):214-8.

PMID:
9764337
4.

Pentoxifylline as a supportive agent in the treatment of cerebral malaria in children.

Di Perri G, Di Perri IG, Monteiro GB, Bonora S, Hennig C, Cassatella M, Micciolo R, Vento S, Dusi S, Bassetti D, et al.

J Infect Dis. 1995 May;171(5):1317-22.

PMID:
7751709
5.
6.

Drug survival, efficacy and toxicity of monotherapy with a fully human anti-tumour necrosis factor-alpha antibody compared with methotrexate in long-standing rheumatoid arthritis.

Barrera P, van der Maas A, van Ede AE, Kiemeney BA, Laan RF, van de Putte LB, van Riel PL.

Rheumatology (Oxford). 2002 Apr;41(4):430-9.

7.

Effect of phenobarbital on seizure frequency and mortality in childhood cerebral malaria: a randomised, controlled intervention study.

Crawley J, Waruiru C, Mithwani S, Mwangi I, Watkins W, Ouma D, Winstanley P, Peto T, Marsh K.

Lancet. 2000 Feb 26;355(9205):701-6.

PMID:
10703801
8.

Exhaled nitric oxide in children with asthma receiving Xolair (omalizumab), a monoclonal anti-immunoglobulin E antibody.

Silkoff PE, Romero FA, Gupta N, Townley RG, Milgrom H.

Pediatrics. 2004 Apr;113(4):e308-12.

PMID:
15060258
9.
10.

Residual neurologic sequelae after childhood cerebral malaria.

van Hensbroek MB, Palmer A, Jaffar S, Schneider G, Kwiatkowski D.

J Pediatr. 1997 Jul;131(1 Pt 1):125-9.

PMID:
9255203
11.

Plasma IP-10, apoptotic and angiogenic factors associated with fatal cerebral malaria in India.

Jain V, Armah HB, Tongren JE, Ned RM, Wilson NO, Crawford S, Joel PK, Singh MP, Nagpal AC, Dash AP, Udhayakumar V, Singh N, Stiles JK.

Malar J. 2008 May 19;7:83. doi: 10.1186/1475-2875-7-83.

12.

The pattern of neurological sequelae of childhood cerebral malaria among survivors in Calabar, Nigeria.

Meremikwu MM, Asindi AA, Ezedinachi E.

Cent Afr J Med. 1997 Aug;43(8):231-4.

PMID:
9431762
13.

Rituximab for rheumatoid arthritis refractory to anti-tumor necrosis factor therapy: Results of a multicenter, randomized, double-blind, placebo-controlled, phase III trial evaluating primary efficacy and safety at twenty-four weeks.

Cohen SB, Emery P, Greenwald MW, Dougados M, Furie RA, Genovese MC, Keystone EC, Loveless JE, Burmester GR, Cravets MW, Hessey EW, Shaw T, Totoritis MC; REFLEX Trial Group.

Arthritis Rheum. 2006 Sep;54(9):2793-806.

14.

A randomised, double-blind, placebo-controlled clinical trial of vitamin A in severe malaria in hospitalised Mozambican children.

Varandas L, Julien M, Gomes A, Rodrigues P, Van Lerberghe W, Malveiro F, Aguiar P, Kolsteren P, Van Der Stuyft P, Hilderbrand K, Labadarios D, Ferrinho P.

Ann Trop Paediatr. 2001 Sep;21(3):211-22.

PMID:
11579859
15.

Myocardial and vascular adrenergic alterations in a rat model of endotoxin shock: reversal by an anti-tumor necrosis factor-alpha monoclonal antibody.

Boillot A, Massol J, Maupoil V, Grelier R, Bernard B, Capellier G, Berthelot A, Barale F.

Crit Care Med. 1997 Mar;25(3):504-11.

PMID:
9118669
16.

Vitamin A supplements ameliorate the adverse effect of HIV-1, malaria, and diarrheal infections on child growth.

Villamor E, Mbise R, Spiegelman D, Hertzmark E, Fataki M, Peterson KE, Ndossi G, Fawzi WW.

Pediatrics. 2002 Jan;109(1):E6.

PMID:
11773574
17.

The ratio of reactive nitrogen intermediates to tumour necrosis factor and clinical outcome of falciparum malaria disease.

al-Yaman FM, Genton B, Clark IA.

Trans R Soc Trop Med Hyg. 1998 Jul-Aug;92(4):417-20.

PMID:
9850396
18.

Cerebrospinal fluid and serum biomarkers of cerebral malaria mortality in Ghanaian children.

Armah HB, Wilson NO, Sarfo BY, Powell MD, Bond VC, Anderson W, Adjei AA, Gyasi RK, Tettey Y, Wiredu EK, Tongren JE, Udhayakumar V, Stiles JK.

Malar J. 2007 Nov 12;6:147.

19.

Effect of a chimeric antibody to tumor necrosis factor-alpha on cytokine and physiologic responses in patients with severe sepsis--a randomized, clinical trial.

Clark MA, Plank LD, Connolly AB, Streat SJ, Hill AA, Gupta R, Monk DN, Shenkin A, Hill GL.

Crit Care Med. 1998 Oct;26(10):1650-9.

PMID:
9781721
20.

Severe malaria in Cameroonian children: correlation between plasma levels of three soluble inducible adhesion molecules and TNF-alpha.

Tchinda VH, Tadem AD, Tako EA, Tene G, Fogako J, Nyonglema P, Sama G, Zhou A, Leke RG.

Acta Trop. 2007 Apr;102(1):20-8. Epub 2007 Feb 27.

PMID:
17397790
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk